[ad_1]
jetcityimage/iStock Editorial through Getty Pictures
Eli Lilly stated its Q1 earnings report will embrace acquired IPR&D expenses of roughly $111M on a pre-tax foundation, amounting round $0.10 per share on a GAAP and adjusted foundation.
The corporate’s Q1 report has not but been finalized and precise outcomes might differ from its preliminary estimates, in accordance with a press release posted on its web site.
Lilly is predicted to launch its Q1 earnings report on April 30.
[ad_2]
Source link
Add comment